Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

AIRS vs DBVT vs ALKS vs SKIN vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AIRS
AirSculpt Technologies, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$216M
5Y Perf.-78.2%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-34.0%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+16.9%
SKIN
The Beauty Health Company

Household & Personal Products

Consumer DefensiveNASDAQ • US
Market Cap$118M
5Y Perf.-96.7%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-74.0%

AIRS vs DBVT vs ALKS vs SKIN vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AIRS logoAIRS
DBVT logoDBVT
ALKS logoALKS
SKIN logoSKIN
PRGO logoPRGO
IndustryMedical - Care FacilitiesBiotechnologyBiotechnologyHousehold & Personal ProductsDrug Manufacturers - Specialty & Generic
Market Cap$216M$1712.35T$5.90B$118M$1.61B
Revenue (TTM)$158M$0.00$1.56B$296M$4.18B
Net Income (TTM)$-18M$-168M$153M$-6M$-1.82B
Gross Margin64.0%65.4%64.9%34.2%
Operating Margin-9.3%12.3%-3.6%-4.1%
Forward P/E24.8x5.6x
Total Debt$105M$22M$70M$379M$3.97B
Cash & Equiv.$8M$194M$1.12B$233M$532M

AIRS vs DBVT vs ALKS vs SKIN vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AIRS
DBVT
ALKS
SKIN
PRGO
StockOct 21May 26Return
AirSculpt Technolog… (AIRS)10021.8-78.2%
DBV Technologies S.… (DBVT)10066.0-34.0%
Alkermes plc (ALKS)100116.9+16.9%
The Beauty Health C… (SKIN)1003.3-96.7%
Perrigo Company plc (PRGO)10026.0-74.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: AIRS vs DBVT vs ALKS vs SKIN vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS and PRGO are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Perrigo Company plc is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. DBVT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AIRS
AirSculpt Technologies, Inc.
The Healthcare Pick

AIRS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
ALKS
Alkermes plc
The Growth Play

ALKS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
  • -11.0% 10Y total return vs PRGO's -77.7%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • 9.8% margin vs PRGO's -43.5%
Best for: growth exposure and long-term compounding
SKIN
The Beauty Health Company
The Quality Angle

Among these 5 stocks, SKIN doesn't own a clear edge in any measured category.

Best for: consumer defensive exposure
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Beta 1.18, yield 9.8%, current ratio 2.76x
  • -2.8% revenue growth vs DBVT's -100.0%
  • Lower P/E (5.6x vs 24.8x)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthPRGO logoPRGO-2.8% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 24.8x)
Quality / MarginsALKS logoALKS9.8% margin vs PRGO's -43.5%
Stability / SafetyALKS logoALKSBeta 1.06 vs AIRS's 3.37, lower leverage
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs AIRS's 0.1%, (3 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

AIRS vs DBVT vs ALKS vs SKIN vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AIRSAirSculpt Technologies, Inc.
FY 2024
Reportable Segment
100.0%$180M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
SKINThe Beauty Health Company
FY 2025
Consumables
70.7%$213M
Delivery Systems
29.3%$88M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

AIRS vs DBVT vs ALKS vs SKIN vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGSKIN

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 5 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$158M$0$1.6B$296M$4.2B
EBITDAEarnings before interest/tax-$2M-$112M$212M$9M$58M
Net IncomeAfter-tax profit-$18M-$168M$153M-$6M-$1.8B
Free Cash FlowCash after capex$2M-$151M$392M$29M$108M
Gross MarginGross profit ÷ Revenue+64.0%+65.4%+64.9%+34.2%
Operating MarginEBIT ÷ Revenue-9.3%+12.3%-3.6%-4.1%
Net MarginNet income ÷ Revenue-11.4%+9.8%-2.0%-43.5%
FCF MarginFCF ÷ Revenue+1.6%+25.1%+9.8%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year-17.8%+28.2%-6.7%-7.2%
EPS Growth (YoY)Latest quarter vs prior year-50.0%+91.5%-4.1%+38.0%-56.4%
ALKS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 5 comparable metrics.

On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than SKIN's 7331.2x.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
Market CapShares × price$216M$1712.35T$5.9B$118M$1.6B
Enterprise ValueMkt cap + debt − cash$313M$1712.35T$4.9B$264M$5.1B
Trailing P/EPrice ÷ TTM EPS-24.71x-0.76x24.76x-5.69x-1.14x
Forward P/EPrice ÷ next-FY EPS est.5.56x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple31.06x17.25x7331.15x7.42x
Price / SalesMarket cap ÷ Revenue1.20x4.00x0.39x0.38x
Price / BookPrice ÷ Book value/share2.52x0.66x3.28x2.02x0.55x
Price / FCFMarket cap ÷ FCF12.28x3.17x11.12x
PRGO leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs AIRS's 2/9, reflecting strong financial health.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-21.8%-130.2%+8.8%-9.4%-50.7%
ROA (TTM)Return on assets-9.0%-89.0%+5.4%-1.2%-19.8%
ROICReturn on invested capital-0.8%+18.9%-6.8%+3.7%
ROCEReturn on capital employed-1.0%-145.7%+14.2%-4.5%+4.3%
Piotroski ScoreFundamental quality 0–924774
Debt / EquityFinancial leverage1.32x0.13x0.04x6.20x1.35x
Net DebtTotal debt minus cash$97M-$172M-$1.0B$146M$3.4B
Cash & Equiv.Liquid assets$8M$194M$1.1B$233M$532M
Total DebtShort + long-term debt$105M$22M$70M$379M$4.0B
Interest CoverageEBIT ÷ Interest expense-1.82x-189.82x32.30x0.81x-7.20x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $707 for SKIN. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs SKIN's -56.4% — a key indicator of consistent wealth creation.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date+87.0%+4.9%+25.3%-35.0%-13.5%
1-Year ReturnPast 12 months+35.2%+110.4%+16.5%-35.9%-51.2%
3-Year ReturnCumulative with dividends-34.0%+19.7%+14.5%-91.7%-58.1%
5-Year ReturnCumulative with dividends-75.6%-69.1%+60.9%-92.9%-60.1%
10-Year ReturnCumulative with dividends-75.6%-87.0%-11.0%-91.6%-77.7%
CAGR (3Y)Annualised 3-year return-12.9%+6.2%+4.6%-56.4%-25.2%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than AIRS's 3.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs AIRS's 28.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5003.37x1.26x1.06x2.00x1.18x
52-Week HighHighest price in past year$12.00$26.18$36.60$2.69$28.44
52-Week LowLowest price in past year$1.51$7.53$25.17$0.76$9.23
% of 52W HighCurrent price vs 52-week peak+28.8%+76.3%+96.7%+33.8%+41.2%
RSI (14)Momentum oscillator 0–10070.048.160.252.160.9
Avg Volume (50D)Average daily shares traded3.1M252K2.3M760K3.4M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: AIRS as "Hold", DBVT as "Buy", ALKS as "Buy", SKIN as "Hold", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). For income investors, PRGO offers the higher dividend yield at 9.81% vs AIRS's 0.13%.

MetricAIRS logoAIRSAirSculpt Technol…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHoldHold
Price TargetConsensus 12-month target$6.00$46.33$44.00$1.30$20.00
# AnalystsCovering analysts515281336
Dividend YieldAnnual dividend ÷ price+0.1%+9.8%
Dividend StreakConsecutive years of raises00010
Dividend / ShareAnnual DPS$0.00$1.15
Buyback YieldShare repurchases ÷ mkt cap+0.4%0.0%+0.5%0.0%0.0%
PRGO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ALKS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallAlkermes plc (ALKS)Leads 3 of 6 categories
Loading custom metrics...

AIRS vs DBVT vs ALKS vs SKIN vs PRGO: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is AIRS or DBVT or ALKS or SKIN or PRGO a better buy right now?

For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.

8% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — AIRS or DBVT or ALKS or SKIN or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — AIRS or DBVT or ALKS or SKIN or PRGO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus AirSculpt Technologies, Inc. 's 3. 37β — meaning AIRS is approximately 218% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

04

Which is growing faster — AIRS or DBVT or ALKS or SKIN or PRGO?

By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.

8% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, AIRS leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — AIRS or DBVT or ALKS or SKIN or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is AIRS or DBVT or ALKS or SKIN or PRGO more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

07

Which pays a better dividend — AIRS or DBVT or ALKS or SKIN or PRGO?

In this comparison, PRGO (9.

8% yield), AIRS (0. 1% yield) pay a dividend. DBVT, ALKS, SKIN do not pay a meaningful dividend and should not be held primarily for income.

08

Is AIRS or DBVT or ALKS or SKIN or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between AIRS and DBVT and ALKS and SKIN and PRGO?

These companies operate in different sectors (AIRS (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and SKIN (Consumer Defensive) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AIRS is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while AIRS, DBVT, ALKS, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AIRS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 38%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

SKIN

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Gross Margin > 38%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.